[Form 4] Quanterix Corporation Insider Trading Activity
Quanterix Corporation (QTRX) 鈥� Form 4 insider transaction
Director Sarah E. Hlavinka reported the acquisition of 2,615 shares of Quanterix common stock on 07/01/2025. The shares were granted in lieu of cash fees for Board and committee service for the second quarter of 2025 and were valued at the Nasdaq closing price of $6.69 on the grant date. No shares were sold.
After the award, Hlavinka鈥檚 total beneficial ownership stands at 60,070 shares, which includes 7,435 restricted stock units. All holdings are reported as directly owned. The filing, signed by Brian Keane under power of attorney on 07/03/2025, involves a single reporting person who serves solely as a director. No derivative securities or additional transactions were disclosed.
Quanterix Corporation (QTRX) 鈥� Transazione interna Form 4
La direttrice Sarah E. Hlavinka ha comunicato l'acquisizione di 2.615 azioni ordinarie di Quanterix il 01/07/2025. Le azioni sono state concesse in sostituzione delle commissioni in contanti per il servizio nel Consiglio e nelle commissioni nel secondo trimestre del 2025 e sono state valutate al prezzo di chiusura Nasdaq di 6,69 $ alla data di assegnazione. Nessuna azione 猫 stata venduta.
Dopo l'assegnazione, la propriet脿 effettiva totale di Hlavinka ammonta a 60.070 azioni, comprese 7.435 unit脿 azionarie vincolate. Tutte le partecipazioni sono riportate come detenute direttamente. La comunicazione, firmata da Brian Keane con procura il 03/07/2025, riguarda una sola persona che ricopre esclusivamente il ruolo di direttore. Non sono stati rivelati titoli derivati o ulteriori transazioni.
Quanterix Corporation (QTRX) 鈥� Transacci贸n interna Formulario 4
La directora Sarah E. Hlavinka inform贸 la adquisici贸n de 2,615 acciones comunes de Quanterix el 01/07/2025. Las acciones se otorgaron en lugar de honorarios en efectivo por el servicio en la Junta y comit茅s durante el segundo trimestre de 2025 y se valoraron al precio de cierre del Nasdaq de $6.69 en la fecha de concesi贸n. No se vendieron acciones.
Tras la adjudicaci贸n, la propiedad beneficiaria total de Hlavinka es de 60,070 acciones, que incluyen 7,435 unidades de acciones restringidas. Todas las participaciones se reportan como propiedad directa. La presentaci贸n, firmada por Brian Keane bajo poder notarial el 03/07/2025, involucra a una 煤nica persona reportante que se desempe帽a 煤nicamente como directora. No se divulgaron valores derivados ni transacciones adicionales.
Quanterix Corporation (QTRX) 鈥� Form 4 雮措秬鞛� 瓯半灅 氤搓碃
鞚挫偓 Sarah E. Hlavinka電� 2025雲� 7鞗� 1鞚� Quanterix 氤错喌欤� 2,615欤茧ゼ 旆摑頄堧嫟瓿� 氤搓碃頄堨姷雼堧嫟. 頃措嫻 欤检嫕鞚� 2025雲� 2攵勱赴 鞚挫偓須� 氚� 鞙勳洂須� 靹滊箘鞀れ棎 雽�頃� 順勱笀 靾橃垬耄� 雽�鞁� 歆�旮夒悩鞐堨溂氅�, 攵�鞐澕 旮办 Nasdaq 膦呹皜 $6.69搿� 韽夑皜霅橃棃鞀惦媹雼�. 欤检嫕鞚� 毵る弰霅橃 鞎婌晿鞀惦媹雼�.
靾橃棳 頉� Hlavinka鞚� 齑� 鞁れ 靻岇湢 欤检嫕鞚� 60,070欤�搿�, 鞚� 欷� 7,435欤� 鞝滍暅 欤检嫕 雼渼臧� 韽暔霅橃柎 鞛堨姷雼堧嫟. 氇摖 氤挫湢 欤检嫕鞚� 歆侅爲 靻岇湢搿� 氤搓碃霅橃棃鞀惦媹雼�. 2025雲� 7鞗� 3鞚� Brian Keane鞚� 鞙勳瀯鞛レ潉 韱淀暣 靹滊獏頃� 鞚� 氤搓碃電� 雼澕 氤搓碃鞛愲靹� 鞚挫偓歆侂鞚� 靾橅枆頃橂姅 鞚鸽瓿� 甏�霠悩氅�, 韺岇儩 歃濌秾鞚措倶 於旉皜 瓯半灅電� 瓿店皽霅橃 鞎婌晿鞀惦媹雼�.
Quanterix Corporation (QTRX) 鈥� Transaction d'initi茅 Formulaire 4
La directrice Sarah E. Hlavinka a d茅clar茅 l'acquisition de 2 615 actions ordinaires de Quanterix le 01/07/2025. Les actions ont 茅t茅 attribu茅es en lieu et place des honoraires en esp猫ces pour le service au conseil d'administration et aux comit茅s au deuxi猫me trimestre 2025, et ont 茅t茅 valoris茅es au cours de cl么ture Nasdaq de 6,69 $ 脿 la date d'attribution. Aucune action n'a 茅t茅 vendue.
Apr猫s cette attribution, la d茅tention effective totale de Hlavinka s'茅l猫ve 脿 60 070 actions, incluant 7 435 unit茅s d'actions restreintes. Tous les avoirs sont d茅clar茅s comme d茅tenus directement. Le d茅p么t, sign茅 par Brian Keane sous procuration le 03/07/2025, concerne une seule personne d茅clarante exer莽ant uniquement en tant que directrice. Aucune valeur d茅riv茅e ni transaction suppl茅mentaire n'a 茅t茅 divulgu茅e.
Quanterix Corporation (QTRX) 鈥� Form 4 Insider-Transaktion
Direktorin Sarah E. Hlavinka meldete den Erwerb von 2.615 Quanterix-Stammaktien am 01.07.2025. Die Aktien wurden anstelle von Barverg眉tungen f眉r die Vorstandst盲tigkeit und Ausschussarbeit im zweiten Quartal 2025 gew盲hrt und zum Nasdaq-Schlusskurs von 6,69 $ am Gew盲hrungstag bewertet. Es wurden keine Aktien verkauft.
Nach der Zuteilung bel盲uft sich Hlavinkas gesamtes wirtschaftliches Eigentum auf 60.070 Aktien, einschlie脽lich 7.435 Restricted Stock Units. Alle Best盲nde werden als direkt gehalten gemeldet. Die Einreichung, unterzeichnet von Brian Keane per Vollmacht am 03.07.2025, betrifft eine einzelne meldende Person, die ausschlie脽lich als Direktor t盲tig ist. Es wurden keine Derivate oder weitere Transaktionen offengelegt.
- None.
- None.
Insights
TL;DR: Routine board stock grant (~$17k); immaterial to QTRX valuation; neutral signal for investors.
The filing reflects a standard quarterly equity retainer issued to Director Sarah E. Hlavinka. At 2,615 shares priced at $6.69, the grant value is roughly $17,500鈥攊mmaterial relative to Quanterix鈥檚 market capitalization. No disposals occurred, and post-grant ownership of 60,070 shares (including 7,435 RSUs) does not represent a concentration change large enough to influence float or insider ownership percentages. Consequently, the transaction is best viewed as routine compensation rather than an indicator of insider sentiment. Impact on share price or liquidity is expected to be negligible.
TL;DR: Equity-in-lieu cash retainer aligns director with shareholders; governance-positive but financially minor.
Issuing equity instead of cash reinforces alignment between directors and shareholders, consistent with widely accepted governance practices. The award size (2,615 shares) is modest and mirrors prior quarter grants, suggesting policy continuity rather than a strategic shift. No 10b5-1 plan is referenced, and the filing ticks the Rule 16 boxes correctly. From a governance lens the move is favorable, but given its scale it does not materially alter insider ownership dynamics or voting power.
Quanterix Corporation (QTRX) 鈥� Transazione interna Form 4
La direttrice Sarah E. Hlavinka ha comunicato l'acquisizione di 2.615 azioni ordinarie di Quanterix il 01/07/2025. Le azioni sono state concesse in sostituzione delle commissioni in contanti per il servizio nel Consiglio e nelle commissioni nel secondo trimestre del 2025 e sono state valutate al prezzo di chiusura Nasdaq di 6,69 $ alla data di assegnazione. Nessuna azione 猫 stata venduta.
Dopo l'assegnazione, la propriet脿 effettiva totale di Hlavinka ammonta a 60.070 azioni, comprese 7.435 unit脿 azionarie vincolate. Tutte le partecipazioni sono riportate come detenute direttamente. La comunicazione, firmata da Brian Keane con procura il 03/07/2025, riguarda una sola persona che ricopre esclusivamente il ruolo di direttore. Non sono stati rivelati titoli derivati o ulteriori transazioni.
Quanterix Corporation (QTRX) 鈥� Transacci贸n interna Formulario 4
La directora Sarah E. Hlavinka inform贸 la adquisici贸n de 2,615 acciones comunes de Quanterix el 01/07/2025. Las acciones se otorgaron en lugar de honorarios en efectivo por el servicio en la Junta y comit茅s durante el segundo trimestre de 2025 y se valoraron al precio de cierre del Nasdaq de $6.69 en la fecha de concesi贸n. No se vendieron acciones.
Tras la adjudicaci贸n, la propiedad beneficiaria total de Hlavinka es de 60,070 acciones, que incluyen 7,435 unidades de acciones restringidas. Todas las participaciones se reportan como propiedad directa. La presentaci贸n, firmada por Brian Keane bajo poder notarial el 03/07/2025, involucra a una 煤nica persona reportante que se desempe帽a 煤nicamente como directora. No se divulgaron valores derivados ni transacciones adicionales.
Quanterix Corporation (QTRX) 鈥� Form 4 雮措秬鞛� 瓯半灅 氤搓碃
鞚挫偓 Sarah E. Hlavinka電� 2025雲� 7鞗� 1鞚� Quanterix 氤错喌欤� 2,615欤茧ゼ 旆摑頄堧嫟瓿� 氤搓碃頄堨姷雼堧嫟. 頃措嫻 欤检嫕鞚� 2025雲� 2攵勱赴 鞚挫偓須� 氚� 鞙勳洂須� 靹滊箘鞀れ棎 雽�頃� 順勱笀 靾橃垬耄� 雽�鞁� 歆�旮夒悩鞐堨溂氅�, 攵�鞐澕 旮办 Nasdaq 膦呹皜 $6.69搿� 韽夑皜霅橃棃鞀惦媹雼�. 欤检嫕鞚� 毵る弰霅橃 鞎婌晿鞀惦媹雼�.
靾橃棳 頉� Hlavinka鞚� 齑� 鞁れ 靻岇湢 欤检嫕鞚� 60,070欤�搿�, 鞚� 欷� 7,435欤� 鞝滍暅 欤检嫕 雼渼臧� 韽暔霅橃柎 鞛堨姷雼堧嫟. 氇摖 氤挫湢 欤检嫕鞚� 歆侅爲 靻岇湢搿� 氤搓碃霅橃棃鞀惦媹雼�. 2025雲� 7鞗� 3鞚� Brian Keane鞚� 鞙勳瀯鞛レ潉 韱淀暣 靹滊獏頃� 鞚� 氤搓碃電� 雼澕 氤搓碃鞛愲靹� 鞚挫偓歆侂鞚� 靾橅枆頃橂姅 鞚鸽瓿� 甏�霠悩氅�, 韺岇儩 歃濌秾鞚措倶 於旉皜 瓯半灅電� 瓿店皽霅橃 鞎婌晿鞀惦媹雼�.
Quanterix Corporation (QTRX) 鈥� Transaction d'initi茅 Formulaire 4
La directrice Sarah E. Hlavinka a d茅clar茅 l'acquisition de 2 615 actions ordinaires de Quanterix le 01/07/2025. Les actions ont 茅t茅 attribu茅es en lieu et place des honoraires en esp猫ces pour le service au conseil d'administration et aux comit茅s au deuxi猫me trimestre 2025, et ont 茅t茅 valoris茅es au cours de cl么ture Nasdaq de 6,69 $ 脿 la date d'attribution. Aucune action n'a 茅t茅 vendue.
Apr猫s cette attribution, la d茅tention effective totale de Hlavinka s'茅l猫ve 脿 60 070 actions, incluant 7 435 unit茅s d'actions restreintes. Tous les avoirs sont d茅clar茅s comme d茅tenus directement. Le d茅p么t, sign茅 par Brian Keane sous procuration le 03/07/2025, concerne une seule personne d茅clarante exer莽ant uniquement en tant que directrice. Aucune valeur d茅riv茅e ni transaction suppl茅mentaire n'a 茅t茅 divulgu茅e.
Quanterix Corporation (QTRX) 鈥� Form 4 Insider-Transaktion
Direktorin Sarah E. Hlavinka meldete den Erwerb von 2.615 Quanterix-Stammaktien am 01.07.2025. Die Aktien wurden anstelle von Barverg眉tungen f眉r die Vorstandst盲tigkeit und Ausschussarbeit im zweiten Quartal 2025 gew盲hrt und zum Nasdaq-Schlusskurs von 6,69 $ am Gew盲hrungstag bewertet. Es wurden keine Aktien verkauft.
Nach der Zuteilung bel盲uft sich Hlavinkas gesamtes wirtschaftliches Eigentum auf 60.070 Aktien, einschlie脽lich 7.435 Restricted Stock Units. Alle Best盲nde werden als direkt gehalten gemeldet. Die Einreichung, unterzeichnet von Brian Keane per Vollmacht am 03.07.2025, betrifft eine einzelne meldende Person, die ausschlie脽lich als Direktor t盲tig ist. Es wurden keine Derivate oder weitere Transaktionen offengelegt.
FAQ
How many QTRX shares did Director Sarah E. Hlavinka acquire on July 1 2025?
What was the price per share for the QTRX stock grant?
What is Sarah E. Hlavinka鈥檚 total ownership in Quanterix after the transaction?
Did the Form 4 report any sale of QTRX shares?
Why were the shares granted to the director?
When was the Form 4 signed and filed?
